Navigation Links
pAcAB4 Baculovirus Transfer Vector from BD Biosciences Pharmingen

ProductspAcAB4 Baculovirus Transfer Vector from BD Biosciences Pharmingen
Company BD Biosciences Pharmingen
Item pAcAB4 Baculovirus Transfer Vector
Price 
Description The pAcAB4 vector is a 10.0 kb Autographa californica (AcNPV) polyhedrin locus-based vector that contains two copies of the AcNPV polyhedrin promoter and two AcNPV p10 promoters. Downstream of the first p10 promoter is a Sma I cloning site, followed by polyhedrin locus-derived termination sequences. Upstream of this, an inverted polyhedrin promoter has been inserted containing Xba I and Stu I as single cloning sites, followed by a second p10 promoter, a Bgl II insertion site and an SV40 termination sequence. Additionally, there is another polyhedrin promoter and BamH I cloning site downstream of the first p10 promoter. This vector allows simultaneous expression of four foreign genes during the very late phase of the Baculovirus infection cycle. This transfer vector is best used in conjunction with BaculoGold DNA (Cat. No. 21100D) or linearized AcRP23.lacZ (Cat. No. 21101D) baculovirus DNA.
Info BD Biosciences PharmingenBD Biosciences Pharmingen
10975 Torreyana Rd.
San Diego, CA 92121
USA
Customer Service: US: 877-232-8995
Tech Support: 800-TALK-TEC (825--5832)
Fax Number: US: 800-325-9637
Web Site: http://www.bdbiosciences.com/pharmingen/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Bac-to-Bac Baculovirus Expression System from Invitrogen
2. Baculovirus Expression System with Gateway Technology from Invitrogen
3. Baculovirus system service from Abgent
4. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
5. Glutathione-S-Transferase-pi EIA Kit from Alpco Diagnostics
6. Quixell Cell Transfer System from Stoelting Co.
7. CryoCool Heat Transfer Fluid from Thermo Scientific
8. Mts-Atf-Biotin Label Transfer Reagent, 5 mg from Pierce Biotechnology, Inc.
9. Mts-Atf-LC-Biotin Label Transfer Reagent, 5 mg. from Pierce Biotechnology, Inc.
10. ProFound Label Transfer Sulfo SBED Protein:Protein Interaction Reagent from Pierce Biotechnology, Inc.
11. Transfer & Blot Paper from NuSep Ltd
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
System Gold® Microbore HPLC with 32 Karat™ Software. from Beckman Coulter
Mimic Sf9 Insect Cells from Invitrogen
... ambient HPLC. Contains connections and on-board d... devices such as RI and/or UV detectors. Also cont...erfacing to strip chart recorders. Includes an inp...r. On-board analog-to-digital conversion with RS-2...
Biology Products:
(Date:11/20/2009)...sts from the Marine Biogeochemistry and Geology an...tory (NRL) organized and led a team of university ...to initiate methane hydrate exploration in the Bea...ediment contribution to Arctic climate change. , ...s a research platform, three cross-shelf transects...
(Date:11/20/2009)...he estimated 4.6 million Americans involved in the...iratory symptoms due to poor air quality in horse ...en earlier this year by investigators at Tufts Uni..., The studywhich polled more than 80 New England...duals working in barns complained of coughing, whe...
(Date:11/20/2009)...l gene into yeast, researchers from Delft Universi... improvements in bioethanol production from agricu... and elimination of the major by-product glycerol,...ntific journal Applied and Environmental Microbio...e yeast Saccharomyces cerevisiae from sugars obtai...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Delft breakthrough in bioethanol production from agricultural waste 2Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 1Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 2Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 3Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 4Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 5Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 6Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 7Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 8Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 9Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 10Osteotech to Present at the Canaccord Adams 29th Annual Global Growth Conference 53893 1InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 1InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 3InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 4InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 5InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 6InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 7InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 8InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 9InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 10InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 11InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 12InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 13InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 14InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 15
...ade by a cancer-causing virus that was thought to ...ically needed by the virus to initiate an infectio...n T lymphotropic virus type 1 (HTLV-1) and a prote...virus, so-called accessory proteins, proteins that...ggested that the virus could live without. , But...
...of transmitting the virus that causes most cases o...ing and informing sexual partners of infection. Th...urnal of Infectious Diseases, now available online...how that knowledge of infection would lead to decr...o others. But Anna Wald, MD, MPH, and colleagues ...
...red a new cellular secret that may explain how cer...rs that makes treatment especially difficult. If t...alled metastasis -- can be understood well enough ... developed for patients with metastatic cancers. ,... Mayo researchers focused on odd protrusions obser...
Other Biology News:Cancer virus protein needed for successful infection 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 3
(Date:11/18/2009)..., Calif., Nov. 18 Sangam...ay that data from the University of Pennsylvania i...amo,s zinc finger nuclease (ZFN) based product, SB...urely disclosed on the internet. ,, Data were p...Pennsylvania School of Medicine from a single subj...
(Date:11/18/2009)...alif., Nov. 18 Masimo ...y(TM) and Measure-Through Motion and Low-Perfusion...-based Uni.H.A., one of the largest healthcare Gro...igned a multi-year purchasing agreement for "gold ... agreement offers preferred contract pricing to Un...
(Date:11/18/2009)...YORK, Nov. 18 Reportlinker.com ann...ble in its catalogue. ,, Biotechnology Reagen...www.reportlinker.com/p0164375/Biotechnology-Reagen...rnewswire&utm_medium=pr&utm_campaign=prnew...omplex chemical compounds used in a range of biote...
(Date:11/18/2009)... Promega Corporation and SwitchGear Genomics ...tein interactions. , Madi...Corporation and SwitchGear Genomics announce a nov...ons. Results of a study using the HaloCHIP™ ...rate the ability to correlate DNA binding events t...
Breaking Biology Technology:Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2